GAMCO Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History

GAMCO Investors’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-58,418	Closed	-$178K	–	890
2024 Q4	$178K	Buy	58,418 +15,932	+37%	+$69.4K	﹤0.01%	843
2024 Q3	$221K	Buy	+42,486	New	+$211K	﹤0.01%	816

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMCO Investors's RVNC Position: Q1 2025 in Review

GAMCO Investors sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 58,418 shares — an estimated $178K sold.

GAMCO Investors first reported a position in RVNC in Q3 2024 and held it in 2 quarters. The position peaked at $221K in Q3 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

GAMCO Investors reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
GAMCO Investors sold 58,418 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $178K.
GAMCO Investors first reported a position in Revance Therapeutics, Inc. in Q3 2024 and held it in 2 quarters.
GAMCO Investors's Revance Therapeutics, Inc. position peaked at $221K in Q3 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on GAMCO Investors's 13F filing for Q1 2025, filed 14 May 2025.